CHEMIESYNT logo

Chemiesynth (Vapi) Ltd

CHEMIESYNT·BSE·
₹119.97▲ +0.00 (+0.00%)
Market Cap36.83 Cr
PE Ratio-25.80
Volume25
Day High - Low119.97 - 119.97
52W High-Low119.97 - 35.84

Chemiesynth (Vapi) Ltd (CHEMIESYNT): company summary

The company's revenue grew 13.5% annually, but net profit turned from a zero loss to a ₹1 crore loss, widening the net profit margin from -0.6% to -4.6%.

Chemiesynth (Vapi) Ltd (CHEMIESYNT) is a micro-cap Chemicals company valued at ₹37 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move
Chemiesynth (Vapi) Ltd last traded at ₹119.97, unchanged on the day.
Recent developments
2026-09-30: Promoter holding remained at 62.35%, with no changes in foreign or domestic institutional holdings. 2026-06-30: The company reported a net loss of ₹1 crore for the latest quarter, continuing a trend of widening losses from the previous year.
Financial performance
The company's revenue grew 13.5% annually, but net profit turned from a zero loss to a ₹1 crore loss, widening the net profit margin from -0.6% to -4.6%. In the latest quarter, revenue rose 5.8% year-on-year, but the net loss widened from ₹0 crore to ₹1 crore, with the net profit margin dropping to -4.6%.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.87 times book value.
Things to watch
The company reported a net loss of ₹1 crore in its latest financial year, with the net profit margin worsening to -4.6%. The debt to equity ratio stands at 1.59, indicating higher leverage. The latest quarter net loss widened from ₹0 crore to ₹1 crore, showing persistent pressure on profitability.
Where it stands
Chemiesynth (Vapi) Ltd ended its latest quarter with a net loss of ₹1 crore, continuing a trend of widening losses from the previous year. The net profit margin dropped to -4.6%, and the debt to equity ratio remains at 1.59. The stock is at its 52-week high, with no institutional holdings reported.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
2.6/10
Poor
Fair Value
Sign in to see
ROE
-9.84%
Weak
P/E
-25.80x
Loss-making
Debt / Equity
1.59
High
Industry
Chemicals
Specialty Chemicals
Overall View
Mixed

Price performance

52W₹35.84
₹119.97
DocStoX take

Supported by momentum (7.5), but held back by growth (0.7). Momentum looks strong at 7.5, but that is offset by growth at 0.7 and quality at 1.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.6
/10
Poor
Quality
Weak
ROE -9.8%
Valuation
Fair
P/B 2.9× on assets (no earnings to value)
Growth
Flat
Revenue +1.5% 5Y CAGR
Risk
Elevated
D/E 1.59
Momentum
Strong
100% of 52-week range

At a glance

Market Cap
₹37 Cr
52W High / Low
₹120 / ₹36
Dividend Yield
0.00%
Promoter Holding
62.35%
EPS (TTM)
₹-3.22
Book Value
₹32.75

Key highlights

  • Loss-making — no meaningful P/E
  • High leverage — debt is 1.6× equity
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Specialty Chemicals

Chemiesynth (Vapi) Ltd peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.